Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DYNC2H1 DNAH1 DNAH8 DNAH9	1.35e-05	18	168	4	GO:0008569
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DYNC2H1 DNAH1 DNAH8 DNAH9	8.45e-05	28	168	4	GO:0051959
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCC3 DYNC2H1 KIF16B PEX1 SRP54 CHD1 SMARCAD1 ABCE1 NAV1 DDX60L DNAH8 DNAH9 DDX4	9.53e-05	441	168	13	GO:0016887
GeneOntologyMolecularFunction	dynein intermediate chain binding	DYNC2H1 DNAH1 DNAH8 DNAH9	2.57e-04	37	168	4	GO:0045505
GeneOntologyMolecularFunction	microtubule motor activity	DYNC2H1 KIF16B DNAH1 DNAH8 DNAH9	3.09e-04	70	168	5	GO:0003777
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DNAH1 DNAH8 DNAH9	5.10e-06	14	162	4	IPR024317
Domain	Dynein_HC_stalk	DYNC2H1 DNAH1 DNAH8 DNAH9	5.10e-06	14	162	4	IPR024743
Domain	Dynein_heavy_dom-2	DYNC2H1 DNAH1 DNAH8 DNAH9	5.10e-06	14	162	4	IPR013602
Domain	DHC_N2	DYNC2H1 DNAH1 DNAH8 DNAH9	5.10e-06	14	162	4	PF08393
Domain	ATPase_dyneun-rel_AAA	DYNC2H1 DNAH1 DNAH8 DNAH9	5.10e-06	14	162	4	IPR011704
Domain	MT	DYNC2H1 DNAH1 DNAH8 DNAH9	5.10e-06	14	162	4	PF12777
Domain	AAA_8	DYNC2H1 DNAH1 DNAH8 DNAH9	5.10e-06	14	162	4	PF12780
Domain	AAA_5	DYNC2H1 DNAH1 DNAH8 DNAH9	5.10e-06	14	162	4	PF07728
Domain	DHC_fam	DYNC2H1 DNAH1 DNAH8 DNAH9	6.91e-06	15	162	4	IPR026983
Domain	Dynein_heavy	DYNC2H1 DNAH1 DNAH8 DNAH9	6.91e-06	15	162	4	PF03028
Domain	Dynein_heavy_dom	DYNC2H1 DNAH1 DNAH8 DNAH9	6.91e-06	15	162	4	IPR004273
Domain	Vinculin/catenin	TLN1 CTNNA3 TLN2	2.19e-05	7	162	3	IPR006077
Domain	DHC_N1	DYNC2H1 DNAH8 DNAH9	3.47e-05	8	162	3	PF08385
Domain	Dynein_heavy_dom-1	DYNC2H1 DNAH8 DNAH9	3.47e-05	8	162	3	IPR013594
Domain	AAA	ABCC3 DYNC2H1 PEX1 SRP54 ABCE1 NAV1 DNAH8 DNAH9	3.74e-05	144	162	8	SM00382
Domain	AAA+_ATPase	ABCC3 DYNC2H1 PEX1 SRP54 ABCE1 NAV1 DNAH8 DNAH9	3.74e-05	144	162	8	IPR003593
Domain	-	TLN1 TLN2	7.48e-05	2	162	2	1.20.1420.10
Domain	SMK-1	PPP4R3A PPP4R3B	7.48e-05	2	162	2	PF04802
Domain	VBS	TLN1 TLN2	7.48e-05	2	162	2	PF08913
Domain	Vinculin-bd_dom	TLN1 TLN2	7.48e-05	2	162	2	IPR015009
Domain	Talin_cent	TLN1 TLN2	7.48e-05	2	162	2	IPR015224
Domain	Talin_middle	TLN1 TLN2	7.48e-05	2	162	2	PF09141
Domain	DUF625	PPP4R3A PPP4R3B	7.48e-05	2	162	2	IPR006887
Domain	-	ABCC3 DLG5 DYNC2H1 PEX1 SRP54 CHD1 SMARCAD1 DNAH1 CASK ARHGAP5 ABCE1 ERAL1 GNL2 NAV1 DDX60L DNAH8 DNAH9 DDX4	8.64e-05	746	162	18	3.40.50.300
Domain	P-loop_NTPase	ABCC3 DLG5 DYNC2H1 KIF16B PEX1 SRP54 CHD1 SMARCAD1 DNAH1 CASK ARHGAP5 ABCE1 ERAL1 GNL2 NAV1 DDX60L DNAH8 DNAH9 DDX4	1.44e-04	848	162	19	IPR027417
Domain	CREPT	RPRD1B RPRD1A	2.23e-04	3	162	2	IPR032337
Domain	CREPT	RPRD1B RPRD1A	2.23e-04	3	162	2	PF16566
Domain	Talin-1	TLN1 TLN2	2.23e-04	3	162	2	IPR015710
Domain	ILWEQ_dom	TLN1 TLN2	4.44e-04	4	162	2	IPR002558
Domain	PXA	SNX13 SNX25	4.44e-04	4	162	2	SM00313
Domain	ILWEQ	TLN1 TLN2	4.44e-04	4	162	2	SM00307
Domain	FERM_f0	TLN1 TLN2	4.44e-04	4	162	2	PF16511
Domain	ILWEQ	TLN1 TLN2	4.44e-04	4	162	2	PD011820
Domain	PXA	SNX13 SNX25	4.44e-04	4	162	2	PS51207
Domain	PXA	SNX13 SNX25	4.44e-04	4	162	2	PF02194
Domain	-	TLN1 TLN2	4.44e-04	4	162	2	1.20.1410.10
Domain	I_LWEQ	TLN1 TLN2	4.44e-04	4	162	2	PF01608
Domain	I_LWEQ	TLN1 TLN2	4.44e-04	4	162	2	PS50945
Domain	Sorting_nexin_C	SNX13 SNX25	4.44e-04	4	162	2	IPR013937
Domain	FERM_f0	TLN1 TLN2	4.44e-04	4	162	2	IPR032425
Domain	Phox_assoc	SNX13 SNX25	4.44e-04	4	162	2	IPR003114
Domain	Nexin_C	SNX13 SNX25	4.44e-04	4	162	2	PF08628
Domain	Creatin/AminoP/Spt16_NTD	XPNPEP1 SUPT16H	7.35e-04	5	162	2	IPR029149
Domain	-	XPNPEP1 SUPT16H	7.35e-04	5	162	2	3.40.350.10
Domain	TPR_2	TMTC2 TTC8 FKBP4 NAA16	9.21e-04	50	162	4	PF07719
Domain	TPR_2	TMTC2 TTC8 FKBP4 NAA16	9.21e-04	50	162	4	IPR013105
Domain	Bromodomain_CS	BAZ2B BRDT EP300	1.44e-03	26	162	3	IPR018359
Domain	RNA_pol_II-bd	RPRD1B RPRD1A	1.53e-03	7	162	2	IPR006903
Domain	CTD_bind	RPRD1B RPRD1A	1.53e-03	7	162	2	PF04818
Domain	RPR	RPRD1B RPRD1A	2.02e-03	8	162	2	SM00582
Domain	CID_dom	RPRD1B RPRD1A	2.02e-03	8	162	2	IPR006569
Domain	CID	RPRD1B RPRD1A	2.02e-03	8	162	2	PS51391
Domain	Pept_M24	XPNPEP1 SUPT16H	2.59e-03	9	162	2	IPR000994
Domain	Peptidase_M24	XPNPEP1 SUPT16H	2.59e-03	9	162	2	PF00557
Domain	-	XPNPEP1 SUPT16H	2.59e-03	9	162	2	3.90.230.10
Domain	fn3	PRTG TNC PTPRD PTPRF PTPRS ROS1	2.92e-03	162	162	6	PF00041
Domain	RGS	SNX13 GRK1 SNX25	3.42e-03	35	162	3	PF00615
Domain	RGS	SNX13 GRK1 SNX25	3.42e-03	35	162	3	SM00315
Domain	RGS	SNX13 GRK1 SNX25	3.71e-03	36	162	3	PS50132
Domain	PTPc	PTPRD PTPRF PTPRS	3.71e-03	36	162	3	SM00194
Domain	Tyr_Pase_AS	PTPRD PTPRF SSH1 PTPRS	3.73e-03	73	162	4	IPR016130
Domain	-	INTS14 CLCA2 ANTXR1 VWA3B	3.92e-03	74	162	4	3.40.50.410
Domain	BROMODOMAIN_1	BAZ2B BRDT EP300	4.01e-03	37	162	3	PS00633
Domain	Bromodomain	BAZ2B BRDT EP300	4.33e-03	38	162	3	PF00439
Domain	RGS	SNX13 GRK1 SNX25	4.66e-03	39	162	3	IPR016137
Domain	TYR_PHOSPHATASE_PTP	PTPRD PTPRF PTPRS	4.66e-03	39	162	3	PS50055
Domain	PTPase_domain	PTPRD PTPRF PTPRS	5.36e-03	41	162	3	IPR000242
Domain	Y_phosphatase	PTPRD PTPRF PTPRS	5.36e-03	41	162	3	PF00102
Domain	BROMODOMAIN_2	BAZ2B BRDT EP300	5.36e-03	41	162	3	PS50014
Domain	WH1	PPP4R3A PPP4R3B	5.48e-03	13	162	2	PS50229
Domain	FN3	PRTG TNC PTPRD PTPRF PTPRS ROS1	5.57e-03	185	162	6	SM00060
Domain	VWFA	INTS14 CLCA2 ANTXR1 VWA3B	5.65e-03	82	162	4	PS50234
Domain	Bromodomain	BAZ2B BRDT EP300	5.74e-03	42	162	3	IPR001487
Domain	BROMO	BAZ2B BRDT EP300	5.74e-03	42	162	3	SM00297
Domain	-	BAZ2B BRDT EP300	5.74e-03	42	162	3	1.20.920.10
Domain	VWA	INTS14 CLCA2 ANTXR1 VWA3B	6.15e-03	84	162	4	SM00327
Domain	Ig_I-set	PRTG ROR1 PTPRD PTPRF PTPRS ALPK2	6.33e-03	190	162	6	IPR013098
Domain	I-set	PRTG ROR1 PTPRD PTPRF PTPRS ALPK2	6.33e-03	190	162	6	PF07679
Domain	IRS	TLN1 TLN2	6.35e-03	14	162	2	PF02174
Domain	IRS_PTB	TLN1 TLN2	6.35e-03	14	162	2	IPR002404
Domain	PX	KIF16B SNX13 SNX25	6.54e-03	44	162	3	SM00312
Domain	TYR_PHOSPHATASE_1	PTPRD PTPRF SSH1 PTPRS	6.67e-03	86	162	4	PS00383
Domain	TYR_PHOSPHATASE_dom	PTPRD PTPRF SSH1 PTPRS	6.95e-03	87	162	4	IPR000387
Domain	TYR_PHOSPHATASE_2	PTPRD PTPRF SSH1 PTPRS	6.95e-03	87	162	4	PS50056
Domain	TPR_1	TMTC2 TTC8 FKBP4 NAA16	7.82e-03	90	162	4	IPR001440
Domain	TPR_1	TMTC2 TTC8 FKBP4 NAA16	7.82e-03	90	162	4	PF00515
Domain	FN3	PRTG TNC PTPRD PTPRF PTPRS ROS1	7.87e-03	199	162	6	PS50853
Domain	-	PTPRD PTPRF SSH1 PTPRS	8.44e-03	92	162	4	3.90.190.10
Domain	Ig-like_fold	PRTG TNC ROR1 CAMTA2 SEMA3A TRIM45 PTPRD PTPRF NFATC2 PTPRS CD274 ROS1 ALPK2	8.64e-03	706	162	13	IPR013783
Pubmed	Protein Tyrosine Phosphatase δ Mediates the Sema3A-Induced Cortical Basal Dendritic Arborization through the Activation of Fyn Tyrosine Kinase.	SEMA3A PTPRD PTPRF PTPRS	3.80e-08	8	170	4	28637841
Pubmed	LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses.	PTPRD PTPRF PTPRS	1.15e-07	3	170	3	31985401
Pubmed	Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation.	PTPRD PTPRF PTPRS	1.15e-07	3	170	3	20139422
Pubmed	Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR.	PTPRD PTPRF PTPRS	1.15e-07	3	170	3	33656439
Pubmed	Developmental expression of the cell adhesion molecule-like protein tyrosine phosphatases LAR, RPTPdelta and RPTPsigma in the mouse.	PTPRD PTPRF PTPRS	1.15e-07	3	170	3	9784606
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	RBM15 SET POLR2G THUMPD1 SRP54 CHD1 SMARCAD1 PPP4R3A RPRD1B PPP4R3B RBM27 ABCE1 ARIH2 SUPT16H MKI67 TOP1 CWF19L1 FKBP4 EP300 ZNF687	1.38e-07	1014	170	20	32416067
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	RPL28 RBM15 RAE1 AHCTF1 RPS11 RBM28 RPRD1B CASK KIAA1217 SUPT16H MKI67 NAV1	2.46e-07	361	170	12	30344098
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	AHCTF1 KIF16B PEX1 THUMPD1 RANBP6 SRP54 RBM28 ARMCX4 CASK CLPTM1L IBTK ABCE1 ERAL1 AASS TMLHE KIAA1217 PANK4 SUPT16H GNL2 NAV1 SENP2 TOP1 FKBP4 DDX4	3.21e-07	1496	170	24	32877691
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RPL28 RBM15 FYTTD1 RAE1 BAZ2B AHCTF1 RPS11 SAP30L RBM28 MBIP TFE3 RPRD1B NGDN RMI1 INTS14 INTS2 RBM27 SUPT16H MKI67 TOP1 EP300 ZNF687	3.98e-07	1294	170	22	30804502
Pubmed	The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1.	PTPRD PTPRF PTPRS	4.57e-07	4	170	3	8524829
Pubmed	Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.	BAZ2B AHCTF1 POLR2G RPS11 CHD1 RPRD1B NGDN SUV39H1 SUPT16H MKI67 TOP1	1.03e-06	340	170	11	29478914
Pubmed	Multiple interactions between receptor protein-tyrosine phosphatase (RPTP) alpha and membrane-distal protein-tyrosine phosphatase domains of various RPTPs.	PTPRD PTPRF PTPRS	1.14e-06	5	170	3	10777529
Pubmed	Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule.	PTPRD PTPRF PTPRS	1.14e-06	5	170	3	22357843
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	RPL28 DLG5 RBM15 RAE1 DYNC2H1 SMARCAD1 NR3C1 PPP4R3A CDC7 PPP4R3B RMI1 BRCA2 KIAA1217 NAV1	1.33e-06	588	170	14	38580884
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	FYTTD1 RAE1 DYNC2H1 POLR2G RPRD1B CASK SEMA3A RPRD1A SUPT16H MKI67 EP300	1.70e-06	358	170	11	32460013
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	RAE1 POLR2G RBM28 PPP4R3A RPRD1B PPP4R3B RPRD1A RBM27 SUPT16H MKI67 GNL2 ZNF687	1.96e-06	440	170	12	34244565
Pubmed	Maturation of ureter-bladder connection in mice is controlled by LAR family receptor protein tyrosine phosphatases.	PTPRD PTPRF PTPRS	2.27e-06	6	170	3	19273906
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	RPL28 SET RPS11 THUMPD1 RANBP6 FRYL SMARCAD1 XPNPEP1 NR3C1 PPP4R3A RPRD1B PPP4R3B RPRD1A APPL2 SETSIP ABCE1 TLN1 ARIH2 PANK4 SUPT16H FKBP4 DNPEP	2.73e-06	1455	170	22	22863883
Pubmed	SIX1 and SIX4 homeoproteins regulate PAX7+ progenitor cell properties during fetal epaxial myogenesis.	TNC TLN1 MKI67 TLN2	3.09e-06	21	170	4	32591430
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	VIL1 DLG5 RBM15 FYTTD1 RAE1 AHCTF1 PEG3 SRP54 RBM28 NGDN ESCO2 ARHGAP5 IBTK RBM27 ERAL1 TLN1 SUPT16H MKI67 GNL2 ROS1 TOP1	3.85e-06	1371	170	21	36244648
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	RPL28 DLG5 DYNC2H1 AHCTF1 KIF16B SRP54 CHD1 SMARCAD1 RBM28 NR3C1 CASK CDC42EP1 CLPTM1L SACS ERAL1 TLN1 PANK4 SUPT16H GNL2 SENP2 PLCH1 FKBP4	3.87e-06	1487	170	22	33957083
Pubmed	Intra- and intermolecular interactions between intracellular domains of receptor protein-tyrosine phosphatases.	PTPRD PTPRF PTPRS	3.96e-06	7	170	3	12376545
Pubmed	Modulation of apoptotic response by LAR family phosphatases-cIAP1 signaling during urinary tract morphogenesis.	PTPRD PTPRF PTPRS	3.96e-06	7	170	3	29073098
Pubmed	Talin regulates integrin β1-dependent and -independent cell functions in ureteric bud development.	TLN1 MKI67 TLN2	3.96e-06	7	170	3	28993400
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	RPL28 RBM15 SET RAE1 AHCTF1 RPS11 CHD1 RBM28 NGDN ARHGAP5 CLPTM1L RBM27 MKI67 GNL2 TOP1 ZNF687	4.58e-06	847	170	16	35850772
Pubmed	Combinatorial expression of neurexins and LAR-type phosphotyrosine phosphatase receptors instructs assembly of a cerebellar circuit.	PTPRD PTPRF PTPRS	6.31e-06	8	170	3	37591863
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	RBM15 FYTTD1 RAE1 BAZ2B AHCTF1 RPS11 CHD1 ESCO2 INTS14 TOP1 EP300	6.33e-06	411	170	11	35182466
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	SET FYTTD1 AHCTF1 PEG3 PEX1 SRP54 FRYL CAMTA2 RBM28 SPATA1 RPRD1B ESCO2 TBCCD1 ARHGAP5 INTS14 INTS2 ABCE1 ERAL1	6.73e-06	1084	170	18	11544199
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RPL28 RBM15 SET DYNC2H1 RPS11 CHD1 SMARCAD1 RPRD1B CLPTM1L RPRD1A CLCA2 ABCE1 ERAL1 TLN1 SUPT16H MKI67 GNL2 TLN2 TOP1 FKBP4 DNPEP	6.95e-06	1425	170	21	30948266
Pubmed	Identification of orphan ligand-receptor relationships using a cell-based CRISPRa enrichment screening platform.	ROR1 PTPRD PTPRF PTPRS	7.57e-06	26	170	4	36178190
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	RBM15 SET RAE1 HEBP2 BAZ2B KCNAB2 SRP54 RBM28 PPP4R3A PPP4R3B RBM27 ABCE1 TLN1 MKI67 TOP1 FKBP4 EP300 ZNF687	8.51e-06	1103	170	18	34189442
Pubmed	Smek promotes corticogenesis through regulating Mbd3's stability and Mbd3/NuRD complex recruitment to genes associated with neurogenesis.	PPP4R3A PPP4R3B MKI67	9.43e-06	9	170	3	28467410
Pubmed	Nine loci for ocular axial length identified through genome-wide association studies, including shared loci with refractive error.	CACNA1D COL8A1 SET GNL2 ARHGAP18	9.77e-06	58	170	5	24144296
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	OR8H2 SET RAE1 AHCTF1 SAP30L PEX1 SMARCAD1 ZNF518A CDC42EP1 INTS14 BRDT SETSIP PANK4 SUPT16H GNL2 TOP1 EP300 ZNF687	9.97e-06	1116	170	18	31753913
Pubmed	The European renal genome project: an integrated approach towards understanding the genetics of kidney development and disease.	GRIK4 TFE3 SLC3A1 MSGN1 PTPRD NFATC2 KIAA1217 CA6	1.05e-05	212	170	8	19521566
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	DNAH1 PPP4R3B IBTK SSH1 RBM27 SENP2 ZNF687	1.10e-05	153	170	7	10718198
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	RBM15 BAZ2B CHD1 ZNF518A CDC7 BRCA2 SUPT16H ZNF687	1.47e-05	222	170	8	37071664
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	RPL28 AHCTF1 RPS11 SRP54 CHD1 NR3C1 PPP4R3A IBTK RBM27 ABCE1 KIAA1217 TLN1 MKI67 GNL2 TOP1 FKBP4	1.54e-05	934	170	16	33916271
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ABCC3 DYNC2H1 TNC KIF16B NR3C1 TFE3 RPRD1B NGDN CLPTM1L ABCE1 AASS EP300 ZNF687	1.69e-05	638	170	13	31182584
Pubmed	PTPσ functions as a presynaptic receptor for the glypican-4/LRRTM4 complex and is essential for excitatory synaptic transmission.	PTPRD PTPRF PTPRS	1.84e-05	11	170	3	25624497
Pubmed	A novel receptor-type protein tyrosine phosphatase with a single catalytic domain is specifically expressed in mouse brain.	PTPRD PTPRF PTPRS	1.84e-05	11	170	3	7832766
Pubmed	TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease.	RAE1 MYLK2 MEIOC SNX25 MKI67	1.99e-05	67	170	5	34644545
Pubmed	Loss of SMEK, a novel, conserved protein, suppresses MEK1 null cell polarity, chemotaxis, and gene expression defects.	PPP4R3A PPP4R3B	2.38e-05	2	170	2	16107728
Pubmed	Ep300 sequestration to functionally distinct glucocorticoid receptor binding loci underlie rapid gene activation and repression.	NR3C1 EP300	2.38e-05	2	170	2	35713523
Pubmed	Clinical significance and interrelations of PD-L1 expression, Ki-67 index, and molecular alterations in sporadic medullary thyroid carcinoma from a Chinese population.	MKI67 CD274	2.38e-05	2	170	2	35920918
Pubmed	The mouse gene Ptprf encoding the leukocyte common antigen-related molecule LAR: cloning, characterization, and chromosomal localization.	PTPRD PTPRF	2.38e-05	2	170	2	7665159
Pubmed	Adaptor Protein APPL2 Affects Adult Antidepressant Behaviors and Hippocampal Neurogenesis via Regulating the Sensitivity of Glucocorticoid Receptor.	NR3C1 APPL2	2.38e-05	2	170	2	28965332
Pubmed	Targeted ablation reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor transcriptional activity.	NR3C1 FKBP4	2.38e-05	2	170	2	19073255
Pubmed	Overexpression, characterization, and purification of a recombinant mouse immunophilin FKBP-52 and identification of an associated phosphoprotein.	NR3C1 FKBP4	2.38e-05	2	170	2	8341706
Pubmed	Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell.	TLN1 TLN2	2.38e-05	2	170	2	26822056
Pubmed	Extracellular rigidity sensing by talin isoform-specific mechanical linkages.	TLN1 TLN2	2.38e-05	2	170	2	26523364
Pubmed	Detection in situ of genomic regulatory elements in Drosophila.	SMARCAD1 KIAA1217	2.38e-05	2	170	2	2827169
Pubmed	TFE3-PD-L1 axis is pivotal for sunitinib resistance in clear cell renal cell carcinoma.	TFE3 CD274	2.38e-05	2	170	2	33145941
Pubmed	The Glucocorticoid Receptor Regulates the ANGPTL4 Gene in a CTCF-Mediated Chromatin Context in Human Hepatic Cells.	NR3C1 ANGPTL4	2.38e-05	2	170	2	28056052
Pubmed	Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer.	NFATC2 SUV39H1	2.38e-05	2	170	2	22079596
Pubmed	3D structure of human FK506-binding protein 52: implications for the assembly of the glucocorticoid receptor/Hsp90/immunophilin heterocomplex.	NR3C1 FKBP4	2.38e-05	2	170	2	15159550
Pubmed	Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus.	NR3C1 FKBP4	2.38e-05	2	170	2	11278753
Pubmed	Enhancer trap integrations in mouse embryonic stem cells give rise to staining patterns in chimaeric embryos with a high frequency and detect endogenous genes.	SMARCAD1 KIAA1217	2.38e-05	2	170	2	1283314
Pubmed	New isoform-specific monoclonal antibodies reveal different sub-cellular localisations for talin1 and talin2.	TLN1 TLN2	2.38e-05	2	170	2	22306379
Pubmed	The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigma.	PTPRD PTPRS	2.38e-05	2	170	2	9566880
Pubmed	Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer.	TNC MUC2	2.38e-05	2	170	2	29999571
Pubmed	Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism.	NR3C1 ANGPTL4	2.38e-05	2	170	2	19628874
Pubmed	Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins.	PTPRD PTPRF PTPRS	2.44e-05	12	170	3	9624153
Pubmed	Smek1/2 is a nuclear chaperone and cofactor for cleaved Wnt receptor Ryk, regulating cortical neurogenesis.	PPP4R3A PPP4R3B MKI67	2.44e-05	12	170	3	29180410
Pubmed	UIF, a New mRNA export adaptor that works together with REF/ALY, requires FACT for recruitment to mRNA.	SET FYTTD1 SUPT16H	3.17e-05	13	170	3	19836239
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DYNC2H1 DNAH1 DNAH8	4.01e-05	14	170	3	9373155
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	RBM15 RAE1 AHCTF1 RBM28 NGDN SUPT16H MKI67 GNL2 DDX60L	4.06e-05	332	170	9	25693804
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	TNC HEATR4 ROR1 LCA5L GRIK4 SLC3A1 SSH1 KIAA1217 ERRFI1 DNAH8	4.53e-05	420	170	10	28065597
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	RAE1 CHD1 SMARCAD1 RBM28 SUPT16H MKI67 GNL2 TOP1 ZNF687	4.99e-05	341	170	9	32971831
Pubmed	Talin 1 and 2 are required for myoblast fusion, sarcomere assembly and the maintenance of myotendinous junctions.	TNC TLN1 TLN2	5.00e-05	15	170	3	19793892
Pubmed	The sperm-associated antigen 6 interactome and its role in spermatogenesis.	CDC7 TTC8 APPL2 MEIOC INTS2 SNX25 FAM209B	5.91e-05	199	170	7	31146259
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	RBM15 POLR2G PPP4R3A CASK CDC42EP1 PPP4R3B ARHGAP5 PTPRD PTPRF SSH1 PTPRS SUPT16H MKI67 GNL2 SENP2 FKBP4	6.16e-05	1049	170	16	27880917
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	RPL28 RBM15 SET FYTTD1 RAE1 RPS11 RBM28 NGDN RBM27 SUPT16H GNL2 TLN2 TOP1	6.83e-05	731	170	13	29298432
Pubmed	Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions.	TLN1 TLN2	7.10e-05	3	170	2	12422220
Pubmed	Immunohistochemical study of DNA topoisomerase I, p53, and Ki-67 in uterine carcinosarcomas.	MKI67 TOP1	7.10e-05	3	170	2	17490723
Pubmed	Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain.	SET EP300	7.10e-05	3	170	2	14612398
Pubmed	Disruption of eyelid and cornea development by targeted overexpression of the glucocorticoid receptor.	NR3C1 MKI67	7.10e-05	3	170	2	12653252
Pubmed	Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome Sequencing.	ROR1 ROS1	7.10e-05	3	170	2	27153396
Pubmed	Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance.	NR3C1 CD274	7.10e-05	3	170	2	34873175
Pubmed	PD-L1 expression in ROS1-rearranged non-small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1.	CD274 ROS1	7.10e-05	3	170	2	30475455
Pubmed	Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells.	TLN1 TLN2	7.10e-05	3	170	2	18792400
Pubmed	Arginylation-dependent regulation of a proteolytic product of talin is essential for cell-cell adhesion.	TLN1 TLN2	7.10e-05	3	170	2	22665520
Pubmed	An essential role for talin during alpha(M)beta(2)-mediated phagocytosis.	TLN1 TLN2	7.10e-05	3	170	2	17202407
Pubmed	Mechanotransduction in talin through the interaction of the R8 domain with DLC1.	TLN1 TLN2	7.10e-05	3	170	2	30028837
Pubmed	Chondroitin Sulfate Proteoglycans Negatively Modulate Spinal Cord Neural Precursor Cells by Signaling Through LAR and RPTPσ and Modulation of the Rho/ROCK Pathway.	PTPRD PTPRF	7.10e-05	3	170	2	25703008
Pubmed	Vinculin and talin: focus on the myocardium.	TLN1 TLN2	7.10e-05	3	170	2	19952892
Pubmed	p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer.	CD274 EP300	7.10e-05	3	170	2	32203167
Pubmed	Activated glucocorticoid receptor interacts with the INHAT component Set/TAF-Ibeta and releases it from a glucocorticoid-responsive gene promoter, relieving repression: implications for the pathogenesis of glucocorticoid resistance in acute undifferentiated leukemia with Set-Can translocation.	SET NR3C1	7.10e-05	3	170	2	18096310
Pubmed	Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced-stage colorectal cancer.	MKI67 CD274	7.10e-05	3	170	2	28782638
Pubmed	Talin depletion reveals independence of initial cell spreading from integrin activation and traction.	TLN1 TLN2	7.10e-05	3	170	2	19160486
Pubmed	Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion.	PTPRD PTPRS	7.10e-05	3	170	2	25394468
Pubmed	Talin and vinculin are downregulated in atherosclerotic plaque; Tampere Vascular Study.	TLN1 TLN2	7.10e-05	3	170	2	27816808
Pubmed	Genome-wide association study of copy number variations (CNVs) with opioid dependence.	PTPRD CTNNA3	7.10e-05	3	170	2	25345593
Pubmed	Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder.	NR3C1 FKBP4	7.10e-05	3	170	2	19545546
Pubmed	Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion.	TLN1 TLN2	7.10e-05	3	170	2	15494027
Pubmed	Role of Ki-67, MRE11, and PD-L1 as Predictive Biomarkers for Recurrence Pattern in Muscle-invasive Bladder Cancer.	MKI67 CD274	7.10e-05	3	170	2	34281845
Pubmed	FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells.	NR3C1 FKBP4	7.10e-05	3	170	2	15591061
Pubmed	Vinculin controls talin engagement with the actomyosin machinery.	TLN1 TLN2	7.10e-05	3	170	2	26634421
Pubmed	Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP).	NFATC2 EP300	7.10e-05	3	170	2	9625762
Pubmed	Loss of mouse cardiomyocyte talin-1 and talin-2 leads to β-1 integrin reduction, costameric instability, and dilated cardiomyopathy.	TLN1 TLN2	7.10e-05	3	170	2	28698364
Interaction	CBX3 interactions	ZNF567 SET AHCTF1 RPS11 CHD1 SMARCAD1 TFE3 ZNF518A NFATC2 RBM27 ABCE1 SUV39H1 SUPT16H MKI67 TOP1 CWF19L1 FKBP4 EP300	4.34e-06	646	161	18	int:CBX3
Interaction	NUP43 interactions	RBM15 RAE1 BAZ2B AHCTF1 CHD1 SMARCAD1 RBM28 MBIP ZNF518A BRCA2 SUPT16H MKI67 GNL2 SENP2 DNAH9 TOP1 ZNF687	1.11e-05	625	161	17	int:NUP43
Interaction	NSUN2 interactions	ROR1 RPS11 RANBP6 RBM28 RPRD1B ABCE1 TLN1 ARIH2 PANK4 GNL2 CD274 ROS1	1.16e-05	323	161	12	int:NSUN2
Interaction	POLR3H interactions	RAE1 POLR2G MBIP RPRD1B RPRD1A APPL2 GNL2	1.47e-05	99	161	7	int:POLR3H
Interaction	POLR1E interactions	BAZ2B POLR2G CHD1 SMARCAD1 RBM28 NR3C1 RPRD1B RPRD1A BRCA2 SUPT16H GNL2 ZNF687	2.56e-05	350	161	12	int:POLR1E
Interaction	CCT8L2 interactions	DYNC2H1 KIF16B PEX1 SMARCAD1 NR3C1 MBIP BRCA2 NAV1	3.89e-05	157	161	8	int:CCT8L2
Interaction	ABCE1 interactions	RPS11 RANBP6 ANKRD30B NR3C1 RPRD1B PTPRF ABCE1 KCTD10 SUPT16H GNL2 CD274 ROS1 EP300	4.45e-05	431	161	13	int:ABCE1
Cytoband	20q13.31	RAE1 MYLK2 FAM209B	2.70e-05	16	170	3	20q13.31
Cytoband	Ensembl 112 genes in cytogenetic band chr1p22	SPATA1 CDC7 CLCA2 BRDT SETSIP	1.65e-04	137	170	5	chr1p22
GeneFamily	Dyneins, axonemal	DNAH1 DNAH8 DNAH9	1.48e-04	17	112	3	536
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRD PTPRF PTPRS	2.84e-04	21	112	3	813
GeneFamily	Olfactory receptors, family 11	OR11H12 OR11H1 OR11H2	3.74e-04	23	112	3	159
GeneFamily	Fibronectin type III domain containing	PRTG TNC PTPRD PTPRF PTPRS ROS1	4.83e-04	160	112	6	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	PRTG ROR1 PTPRD PTPRF PTPRS ALPK2	4.99e-04	161	112	6	593
GeneFamily	Olfactory receptors, family 8	OR8H2 OR8J2 OR8D2	3.47e-03	49	112	3	155
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP5 ARHGAP6 ARHGAP18	3.67e-03	50	112	3	721
GeneFamily	Integrator complex	INTS14 INTS2	3.79e-03	15	112	2	1366
Coexpression	GEORGES_CELL_CYCLE_MIR192_TARGETS	DLG5 TDG CDC7 RAD1 MKI67 TOP1	2.70e-06	62	166	6	M11038
Coexpression	GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN	FYTTD1 BAZ2B KIF16B SRP54 RPRD1A PTPRF SNX25 DEPDC5 FOXC2	5.52e-06	200	166	9	M5081
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	ZNF567 RAE1 AHCTF1 CHD1 FRYL MBIP PPP4R3A SNX13 APPL2 RBM27 ARIH2 FAM209B SENP2 TOP1 CWF19L1 EP300	7.25e-06	680	166	16	M41089
Coexpression	GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_DN	NUDT13 PPP4R3A PPP4R3B INTS14 ANGPTL4 CD274 CCL17 TOP1	4.01e-05	198	166	8	M7035
Coexpression	GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN	BAZ2B RBM28 RPRD1A ERAL1 SUV39H1 MKI67 TOP1 NAA16	4.15e-05	199	166	8	M3191
Coexpression	GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN	BAZ2B PEX1 NUDT13 SPATA1 MYLK2 RPRD1A PLCH1 DNAH8	4.15e-05	199	166	8	M9195
Coexpression	GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN	RAE1 THUMPD1 RANBP6 SMARCAD1 RBM28 CLPTM1L INTS14 SUV39H1	4.30e-05	200	166	8	M6039
Coexpression	GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	DYNC2H1 BAZ2B SMARCAD1 GSAP RPRD1A LUM ARHGAP18 DNAH8	4.30e-05	200	166	8	M9188
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	CACNA1D COL8A1 TNC ROR1 TMTC2 GRIK4 PTPRD ANTXR1 LUM	6.72e-08	197	169	9	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL8A1 TNC CDC42EP1 SEMA3A PTPRD ERRFI1 ANTXR1 LUM FOXC2	7.02e-08	198	169	9	9d61483b0decac2fe90045b3474843360b2c49b3
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL8A1 DYNC2H1 TNC CDC42EP1 PTPRD ERRFI1 ANTXR1 LUM FOXC2	7.02e-08	198	169	9	bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	COL8A1 ROR1 TMTC2 MBIP SNX25 ERRFI1 ROS1 PLCH1	6.29e-07	188	169	8	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ROR1 GSAP MBIP KIAA1217 ERRFI1 CTNNA3 ROS1 PLCH1	6.82e-07	190	169	8	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SLC26A9 MBIP PTPRD SNX25 KIAA1217 ERRFI1 ROS1 PLCH1	7.38e-07	192	169	8	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	CACNA1D TNC GRIK4 ARHGAP6 PTPRD PTPRS ANTXR1 LUM	7.67e-07	193	169	8	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GSAP MBIP PTPRF KIAA1217 ERRFI1 CTNNA3 ROS1 PLCH1	7.67e-07	193	169	8	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL8A1 ROR1 TMTC2 MBIP PTPRF SNX25 ROS1 PLCH1	8.29e-07	195	169	8	9406866f99555198a9be311fbd65751b70f35446
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1D GRIK4 ARHGAP6 PTPRS AASS ANTXR1 TLN2 LUM	8.62e-07	196	169	8	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CACNA1D COL8A1 TNC PTPRD PTPRS AASS ANGPTL4 LUM	1.00e-06	200	169	8	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CACNA1D COL8A1 TNC PTPRD PTPRS AASS ANGPTL4 LUM	1.00e-06	200	169	8	a510deaada669e690329183e18df02870bd204b3
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CACNA1D COL8A1 TNC PTPRD PTPRS AASS ANGPTL4 LUM	1.00e-06	200	169	8	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D CES1 BAZ2B ROR1 MBIP KIAA1217 LUM	5.22e-06	177	169	7	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_10\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HTR2B ROR1 GRIK4 NAV1 PPP1R1C CCL17 ALPK2	5.83e-06	180	169	7	32d871738a24071b70084a7e80148a516110c78b
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_10\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HTR2B ROR1 GRIK4 NAV1 PPP1R1C CCL17 ALPK2	5.83e-06	180	169	7	067ca8a15228c7f3b3bc7aecbc9b1611ca05e176
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA1D ABCC3 SLC3A1 ARHGAP6 PTPRD TLN2 ALPK2	7.22e-06	186	169	7	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TNC CDC42EP1 SEMA3A ANGPTL4 ERRFI1 LUM FOXC2	7.48e-06	187	169	7	f1d0fc625e0e7881b3f290742fd7148d995eb71e
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TNC CDC42EP1 SEMA3A ANGPTL4 ERRFI1 LUM FOXC2	7.48e-06	187	169	7	02e7246ef5ad41773d14426254e139b156d45c1d
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TNC CDC42EP1 SEMA3A ANGPTL4 ERRFI1 LUM FOXC2	7.48e-06	187	169	7	08c73d125e0638c9e9878165bba2442c266c8a48
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1D CES1 DYNC2H1 GRIK4 ARHGAP6 PTPRD LUM	8.02e-06	189	169	7	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	(1)_Osterolineage_cells-(10)_OLC-1\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	COL8A1 PLB1 TNC TMTC2 PTPRD PTPRS LUM	8.02e-06	189	169	7	46c5b975fb9d33017f2d9b7770d45a8bdf95baa2
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D TNC ARHGAP6 PTPRD PTPRS ANTXR1 LUM	8.02e-06	189	169	7	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SET BAZ2B SMARCAD1 NR3C1 ZNF518A PPP4R3B ARHGAP5	8.59e-06	191	169	7	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MBIP PTPRD KIAA1217 ERRFI1 CTNNA3 ROS1 PLCH1	8.59e-06	191	169	7	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ROR1 GSAP MBIP KIAA1217 CTNNA3 ROS1 PLCH1	8.59e-06	191	169	7	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SET BAZ2B SMARCAD1 NR3C1 ZNF518A PPP4R3B ARHGAP5	8.59e-06	191	169	7	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	COL8A1 MBIP PTPRF SNX25 KIAA1217 ROS1 PLCH1	8.89e-06	192	169	7	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRTG SLC26A9 MBIP SNX25 ERRFI1 ROS1 PLCH1	8.89e-06	192	169	7	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	COL8A1 ROR1 TMTC2 PTPRF SNX25 KIAA1217 PLCH1	8.89e-06	192	169	7	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D TNC ROR1 ARHGAP6 PTPRD ANTXR1 LUM	8.89e-06	192	169	7	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRTG SLC26A9 MBIP PTPRD SNX25 ROS1 PLCH1	9.19e-06	193	169	7	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-goblet\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VIL1 ABCC3 FRYL DYRK4 PTPRF CLCA2 MUC2	9.19e-06	193	169	7	402aad2f9e789ad1f2e1536cdc9ce61de7625427
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL8A1 TNC CDC42EP1 KIAA1217 ERRFI1 LUM FOXC2	9.19e-06	193	169	7	5e46a9f65e85aca78f825fdef88a95b97eec8743
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	CACNA1D GRIK4 ARHGAP6 PTPRS ANGPTL4 ANTXR1 LUM	9.19e-06	193	169	7	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VIL1 ABCC3 FRYL DYRK4 PTPRF CLCA2 MUC2	9.19e-06	193	169	7	7ee3b1ef5c455f321b4e154ae62c69543fe9b30e
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRTG SLC26A9 MBIP PTPRD SNX25 ROS1 PLCH1	9.19e-06	193	169	7	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CACNA1D ROR1 GRIK4 ARHGAP6 PTPRD ANTXR1 LUM	9.51e-06	194	169	7	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D TNC ARHGAP6 PTPRD PTPRS ANTXR1 LUM	9.51e-06	194	169	7	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D TNC ARHGAP6 PTPRD PTPRS ANTXR1 LUM	9.51e-06	194	169	7	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	10x5'-blood-Hematopoietic_Erythro-Mega-Megakaryocyte_early\|blood / Manually curated celltypes from each tissue	VIL1 ABCC3 FAXDC2 XPNPEP1 ARHGAP6 TLN1 ARHGAP18	9.51e-06	194	169	7	63dea7d630962761a70aa88e720ee35c22cbc81a
ToppCell	10x5'-blood-Hematopoietic_Erythro-Mega\|blood / Manually curated celltypes from each tissue	VIL1 ABCC3 FAXDC2 XPNPEP1 ARHGAP6 TLN1 ARHGAP18	9.51e-06	194	169	7	d0e7d35b5086834929c4bd39d4c6719b2d5fc71e
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SET SLC26A9 MBIP SNX25 ERRFI1 ROS1 TOP1	9.51e-06	194	169	7	54975e663ed4414b99b3c9a1aa6335613946470f
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA1D ROR1 GRIK4 ARHGAP6 PTPRD ANTXR1 LUM	9.83e-06	195	169	7	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	PCW_07-8.5-Mesenchymal\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CACNA1D ROR1 SEMA3A ARHGAP6 PTPRD ANTXR1 LUM	1.02e-05	196	169	7	8e10802f52e5e1853ea4ad34bf9a32a34e6112b5
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL8A1 TNC CDC42EP1 SEMA3A PTPRD LUM FOXC2	1.02e-05	196	169	7	57df2a57b35be9851ac0b1e5731baa53052511f0
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CACNA1D ROR1 SEMA3A ARHGAP6 PTPRD ANTXR1 LUM	1.05e-05	197	169	7	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA1D ROR1 GRIK4 SEMA3A PTPRD ANTXR1 LUM	1.09e-05	198	169	7	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRTG SLC26A9 MBIP PTPRD SNX25 ROS1 PLCH1	1.09e-05	198	169	7	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	Fibroblasts-HLA-DRA_high_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	COL8A1 DYNC2H1 TNC C1RL CDC42EP1 ANTXR1 LUM	1.09e-05	198	169	7	e8c0fbf306fae13e97caa294d7c99a564bd97130
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	CACNA1D GRIK4 ARHGAP6 PTPRD PTPRS ANTXR1 LUM	1.09e-05	198	169	7	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL8A1 ROR1 TMTC2 MBIP SNX25 ROS1 PLCH1	1.12e-05	199	169	7	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	PCW_10-12-Mesenchymal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA1D ROR1 SEMA3A ARHGAP6 PTPRD ANTXR1 LUM	1.12e-05	199	169	7	a09292de4c4447b8eee55d401808e43b817321cc
ToppCell	tumor_Lung-Epithelial_cells-tS2\|tumor_Lung / Location, Cell class and cell subclass	ABCC3 HEBP2 TNC CDC42EP1 CLPTM1L PTPRF ERRFI1	1.12e-05	199	169	7	28ec59e01061287fb0892491790b316e2b93e232
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DLG5 CES1 TNC ARHGAP5 PTPRF CLCA2 KIAA1217	1.16e-05	200	169	7	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	MS-Multiple_Sclerosis-Others-Platelet\|Multiple_Sclerosis / Disease, condition lineage and cell class	VIL1 ABCC3 AHCTF1 FAXDC2 XPNPEP1 ARHGAP6 ARHGAP18	1.16e-05	200	169	7	263d956136747c209951b4358f2e1672a21d8eef
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL8A1 TNC CDC42EP1 PTPRD ERRFI1 LUM FOXC2	1.16e-05	200	169	7	3c898e81444b001835c3f1bbc68183078701b135
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL8A1 TNC CDC42EP1 PTPRD ERRFI1 LUM FOXC2	1.16e-05	200	169	7	3eca8ffeb41b664fbdbbd70b375c5d953503ab29
ToppCell	metastatic_Lymph_Node-Epithelial_cells-Malignant_cells\|Epithelial_cells / Location, Cell class and cell subclass	ABCC3 TNC MBIP CDC42EP1 CLPTM1L ERRFI1 TOP1	1.16e-05	200	169	7	b16da9c342f9ff5ed4983c65b7d3b59123a594cd
ToppCell	facs-Liver-Hepatocytes\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C1RL F9 PTPRD PTPRF ANGPTL4 ERRFI1	2.93e-05	156	169	6	e2cda3ad4e5f44a80133864c5a38b766afb952ce
ToppCell	ASK452-Epithelial-Type_2\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	HEATR4 DLGAP4 RAD1 SENP2 ROS1 ZNF649	2.93e-05	156	169	6	e2b8d65c38cedb8ec6c3c1b138957145af931c51
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	KCNH7 GRIK4 SEMA3A CTNNA3 DNAH8 DNAH9	3.26e-05	159	169	6	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	ABCC3 NRAP CTNNA3 PPP1R1C DDX60L ARHGAP18	4.74e-05	170	169	6	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	THUMPD1 DYRK4 CDC7 ARHGAP5 MKI67 DDX4	4.74e-05	170	169	6	badbe200e9d5003d23d115955b10b4ea767f6c26
ToppCell	droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC26A9 CDC7 ESCO2 MKI67 PLCH1 ALPK2	4.90e-05	171	169	6	1eebd7138c3b20ddc1104f21615f9df0e776bbe6
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THUMPD1 DYRK4 CDC7 NFATC2 CCL17 DDX4	5.22e-05	173	169	6	15af4a0f7516dbf5c93ba66a19aca073ebe30d04
ToppCell	367C-Lymphocytic-NK_cells-Proliferating_NK_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ESCO2 TRIM45 BRCA2 SUV39H1 MKI67 PPP1R1C	5.57e-05	175	169	6	0b1aaa028ba844d4bcb4509fdab8bee648373935
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NRAP ROR1 CTNNA3 PPP1R1C DDX60L ALPK2	5.75e-05	176	169	6	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PEG3 SRP54 NR3C1 ARHGAP5 IBTK SUPT16H	5.75e-05	176	169	6	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PRTG TNC ROR1 ARHGAP6 KIAA1217 PLCH1	6.71e-05	181	169	6	af92b8b7f455210dab502ef6964f3a0162180759
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D TNC PEG3 TTC8 PTPRD LUM	6.71e-05	181	169	6	9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDC7 ESCO2 SNX25 SUV39H1 MKI67 DNAH8	6.92e-05	182	169	6	bc6a120dedc813c58baac1428c39851a07b71ba7
ToppCell	10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Megakaryocyte_early\|bone_marrow / Manually curated celltypes from each tissue	VIL1 ABCC3 FAXDC2 ARHGAP6 ARHGAP18 PLCH1	7.13e-05	183	169	6	3cc9f3dc3bc4bde1d3408b0a6ba58e135a11036d
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D TNC ROR1 PEG3 PTPRS FOXC2	7.13e-05	183	169	6	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1D RPL28 PEG3 RPS11 NFATC2 TLN2	7.13e-05	183	169	6	7534587fa35837c0aaca93c542f2eee493eba637
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH1 PTPRD TLN2 ROS1 PLCH1 DNAH9	7.35e-05	184	169	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ROR1 GSAP MBIP PTPRF KIAA1217 ERRFI1	7.35e-05	184	169	6	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	PRTG SLC26A9 MBIP SNX25 ROS1 PLCH1	7.35e-05	184	169	6	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH1 PTPRD TLN2 ROS1 PLCH1 DNAH9	7.35e-05	184	169	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH1 PTPRD TLN2 ROS1 PLCH1 DNAH9	7.35e-05	184	169	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VIL1 SLC3A1 PTPRD AASS ERRFI1 TLN2	7.57e-05	185	169	6	3e3217c99719fd1d2fa94e16be7712a7e5077152
ToppCell	droplet-Kidney-nan-3m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VIL1 SLC3A1 PTPRD AASS ERRFI1 TLN2	7.57e-05	185	169	6	0ff4148b4701003d9d594e0da8261176fb13aa59
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL8A1 SLC26A9 MBIP CDC42EP1 SNX25 ROS1	7.57e-05	185	169	6	7460387f48f33674330bd53b759681b264228f5a
ToppCell	Mesenchymal_cells-Osteo-CAR\|World / Lineage and Cell class	COL8A1 PLB1 TNC CDC42EP1 PTPRD ANGPTL4	7.57e-05	185	169	6	16f1588893d09c864e0cb4f837a1b972a1a57baa
ToppCell	Megakaryocytic-erythropoietic-Megakaryo-cells-Platelet\|World / Lineage, cell class and subclass	ABCC3 FAXDC2 XPNPEP1 ARHGAP6 TLN1 ARHGAP18	7.80e-05	186	169	6	27807334e7241c8a9aeaf6403f0fd0b001fbc0d1
ToppCell	Epithelial-C_(AT2)\|World / shred on cell class and cell subclass (v4)	SLC26A9 GSAP MBIP PTPRF SNX25 ERRFI1	7.80e-05	186	169	6	b7b1763fc52b4485d843a4a6727055e6c95ebad3
ToppCell	Mesenchymal_cells-Adipo-CAR\|World / Lineage and Cell class	COL8A1 TNC PTPRD ANGPTL4 ERRFI1 ANTXR1	7.80e-05	186	169	6	6ca8ce7ced91d6308b7c056032ffec1b37c974bf
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ROR1 PEG3 GSAP SACS ERRFI1 TLN2	8.03e-05	187	169	6	69b47f00598d647e2a99427ebddf42c339428e47
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CACNA1D ROR1 GRIK4 SEMA3A ARHGAP6 PTPRD	8.03e-05	187	169	6	a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell	COPD-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	TNC SLC26A9 MBIP SNX25 ROS1 TOP1	8.03e-05	187	169	6	030af361f8bdcd0aff4ec1922702833325cf74d8
ToppCell	droplet-Kidney-nan-18m-Epithelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC3A1 ARHGAP5 PTPRD PTPRF AASS ERRFI1	8.03e-05	187	169	6	236e9857729670e87eed30fad58f49e1f56e4a85
ToppCell	Monocytes-M2-like_CD16+_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	BAZ2B GSAP ARHGAP5 ARHGAP6 BRCA2 ARHGAP18	8.03e-05	187	169	6	59e31c51183ed4c9a3d0792c8005ea3a12b28dfa
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	COL8A1 RMI1 PTPRD PTPRS ANTXR1 LUM	8.27e-05	188	169	6	8231e635706a296db6b6da1029a33bbc1b52478e
ToppCell	21-Trachea-Epithelial-Multiciliated_cell\|Trachea / Age, Tissue, Lineage and Cell class	CFAP107 CES1 DYNC2H1 VWA3B DNAH9 LRRC23	8.27e-05	188	169	6	803bf76a85b3033d2a04b08dd2c03ce9c15529ba
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	MBIP PTPRF SNX25 KIAA1217 ROS1 PLCH1	8.27e-05	188	169	6	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLC26A9 GSAP MBIP PTPRF SNX25 ERRFI1	8.27e-05	188	169	6	7499e353ea5853d06558b20cedee3c7910425d7d
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLC26A9 GSAP MBIP PTPRF SNX25 ERRFI1	8.27e-05	188	169	6	562f5984efdbbcb8f53ddcee033ccbf9eb678425
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	PRTG SLC26A9 MBIP SNX25 ROS1 PLCH1	8.52e-05	189	169	6	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1D TNC ARHGAP6 PTPRD ANTXR1 LUM	8.52e-05	189	169	6	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLC26A9 MBIP PTPRF AASS SNX25 ERRFI1	8.77e-05	190	169	6	8ff8c586237cf15f930416710bcff45205fe6f70
Drug	AC1MIXXG	BAZ2B SMARCAD1 ESCO2 BRDT SUPT16H EP300	8.69e-08	31	166	6	CID003081982
Drug	Cisapride [81098-60-4]; Down 200; 8.6uM; PC3; HT_HG-U133A	ABCC3 ROR1 DLGAP4 KCNAB2 PEX1 C1RL NR3C1 PPP4R3A SEMA3A SENP2	1.76e-06	195	166	10	6706_DN
Disease	autosomal recessive spinocerebellar ataxia 20 (implicated_via_orthology)	SNX13 SNX25	2.92e-05	2	160	2	DOID:0080066 (implicated_via_orthology)
Disease	phosphatidylcholine 38:6 measurement	ABCC3 AHCTF1 DEPDC5	8.32e-05	16	160	3	EFO_0010388
Disease	Malignant neoplasm of breast	DYNC2H1 ROR1 KIF16B SEMA3A CLPTM1L PTPRD RPRD1A CLCA2 BRCA2 SPATA21 ANGPTL4 MKI67 PACC1 DNAH9 TOP1 EP300	2.56e-04	1074	160	16	C0006142
Disease	mucositis (biomarker_via_orthology)	MKI67 MUC2	2.89e-04	5	160	2	DOID:0080178 (biomarker_via_orthology)
Disease	azoospermia (implicated_via_orthology)	PTPRD PTPRF PTPRS	4.16e-04	27	160	3	DOID:14227 (implicated_via_orthology)
Disease	stearoyl sphingomyelin (d18:1/18:0) measurement	CAMTA2 ANGPTL4	4.32e-04	6	160	2	EFO_0800611
Disease	generalized anxiety disorder (implicated_via_orthology)	HTR2B NR3C1	8.01e-04	8	160	2	DOID:14320 (implicated_via_orthology)
Disease	cataract (implicated_via_orthology)	NR3C1 BRCA2 PANK4	1.15e-03	38	160	3	DOID:83 (implicated_via_orthology)
Disease	lung cancer (is_marker_for)	TNC ESCO2 MKI67	1.24e-03	39	160	3	DOID:1324 (is_marker_for)
Disease	long QT syndrome (implicated_via_orthology)	KCNH7 ARHGAP6	1.28e-03	10	160	2	DOID:2843 (implicated_via_orthology)
Disease	autism spectrum disorder (implicated_via_orthology)	HTR2B DLGAP4 CHD1 CASK NAA16	1.47e-03	152	160	5	DOID:0060041 (implicated_via_orthology)
Disease	Barrett's esophagus (is_marker_for)	MKI67 MUC2	1.56e-03	11	160	2	DOID:9206 (is_marker_for)
Disease	Colorectal Carcinoma	ABCC3 PEG3 CHD1 PTPRD SACS PTPRS ABCE1 PANK4 MKI67 DNAH8 EP300	1.62e-03	702	160	11	C0009402
Disease	optic disc area measurement	COL8A1 CDC42EP1 CTNNA3	1.88e-03	45	160	3	EFO_0006937
Disease	response to antineoplastic agent	KIF16B SMARCAD1 SEMA3A PTPRD	2.10e-03	99	160	4	GO_0097327
Disease	urate measurement, bone density	PLB1 BAZ2B AHCTF1 DNAH1 PTPRD ARIH2 NAV1 VWA3B DNAH8 DNAH9	2.11e-03	619	160	10	EFO_0003923, EFO_0004531
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	CES1 SNX13 DNAH1 RMI1 KCTD10 ANGPTL4	2.17e-03	243	160	6	EFO_0004612, EFO_0020944
Disease	Benign tumor of pancreas	BRCA2 EP300	2.19e-03	13	160	2	C0347284
Disease	X-24588 measurement	ABCC3 HEATR4	2.19e-03	13	160	2	EFO_0800898
Disease	1-methylurate measurement	SEMA3A PTPRF	2.55e-03	14	160	2	EFO_0021173
Disease	unipolar depression, mood disorder, response to antidepressant	PTPRD ERRFI1	2.55e-03	14	160	2	EFO_0003761, EFO_0004247, GO_0036276
Disease	pathological myopia	ZNF285 PTPRD ROS1 DNAH9	3.18e-03	111	160	4	EFO_0004207
Disease	5-oxoproline measurement	RMI1 DNAH8	3.34e-03	16	160	2	EFO_0010988
Disease	cancer (implicated_via_orthology)	POLR2G RANBP6 PGK2 BRCA2 DEPDC5 TOP1	3.51e-03	268	160	6	DOID:162 (implicated_via_orthology)
Disease	Drug habituation	APPL2 CTNNA3 CD274 DNAH8	3.61e-03	115	160	4	C0013170
Disease	Drug abuse	APPL2 CTNNA3 CD274 DNAH8	3.61e-03	115	160	4	C0013146
Disease	Prescription Drug Abuse	APPL2 CTNNA3 CD274 DNAH8	3.61e-03	115	160	4	C4316881
Disease	Substance-Related Disorders	APPL2 CTNNA3 CD274 DNAH8	3.61e-03	115	160	4	C0236969
Disease	Drug Use Disorders	APPL2 CTNNA3 CD274 DNAH8	3.61e-03	115	160	4	C0013222
Disease	Drug Dependence	APPL2 CTNNA3 CD274 DNAH8	3.61e-03	115	160	4	C1510472
Disease	Substance Dependence	APPL2 CTNNA3 CD274 DNAH8	3.61e-03	115	160	4	C0038580
Disease	Substance Use Disorders	APPL2 CTNNA3 CD274 DNAH8	3.61e-03	115	160	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	APPL2 CTNNA3 CD274 DNAH8	3.61e-03	115	160	4	C0029231
Disease	Substance abuse problem	APPL2 CTNNA3 CD274 DNAH8	3.72e-03	116	160	4	C0740858
Disease	pre-malignant neoplasm (biomarker_via_orthology)	SUV39H1 MUC2	3.77e-03	17	160	2	DOID:0060071 (biomarker_via_orthology)
Disease	Colorectal Neoplasms	ABCC3 CHD1 PTPRD ABCE1 MKI67 EP300	4.13e-03	277	160	6	C0009404
Disease	pursuit maintenance gain measurement	CACNA1D GSAP PTPRD DDX60L	4.59e-03	123	160	4	EFO_0008433
Disease	Pancreatic carcinoma	BRCA2 EP300	4.70e-03	19	160	2	C0235974
Disease	Deaf Mutism	CACNA1D TMTC2	5.21e-03	20	160	2	C4082305
Disease	Deafness, Acquired	CACNA1D TMTC2	5.21e-03	20	160	2	C0751068
Disease	Hearing Loss, Extreme	CACNA1D TMTC2	5.21e-03	20	160	2	C0086395
Disease	Complete Hearing Loss	CACNA1D TMTC2	5.21e-03	20	160	2	C0581883
Disease	response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement	PTPRD FAM209B	5.21e-03	20	160	2	EFO_0803359, EFO_0803362
Disease	Bilateral Deafness	CACNA1D TMTC2	5.21e-03	20	160	2	C3665473
Disease	blood aluminium measurement	BAZ2B TRIM45	5.21e-03	20	160	2	EFO_0007575
Disease	Prelingual Deafness	CACNA1D TMTC2	5.21e-03	20	160	2	C0011052

Protein segments in the cluster

Peptide	Gene	Start	Entry
VQKLQKYQPRIAVFN	TDG	216	Q13569
SRRQQQKYLGKNSKP	USP26	621	Q9BXU7
YLQIGANTQAAQKLK	CES1	526	P23141
KQRAAKYANSNPQPI	EP300	2086	Q09472
SNKPAVKLLYNRSNN	KCTD10	156	Q9H3F6
AIKKPIQANQYNSRA	HTR2B	156	P41595
GQYFRSIPQQRQKLK	ANGPTL4	361	Q9BY76
AQRKSKSPKINLNYA	ANKRD30B	1236	Q9BXX2
CINFTRVKNNQPAKY	ANTXR1	481	Q9H6X2
NNIAKAGYTKLTPVQ	DDX4	301	Q9NQI0
QENLVKTGRYNPAKQ	CCDC169	176	A6NNP5
PVIKVNSKQRYASNA	DNPEP	381	Q9ULA0
NTKKNGRLTNQLQYL	BRDT	21	Q58F21
GLRSSQQNPKVQKYI	ALPK2	256	Q86TB3
REQYKQAFPSQLKKQ	BAZ2B	431	Q9UIF8
LNSQIKNLSKLLPQY	ADAM18	171	Q9Y3Q7
QIEQLGKKYNINPVS	AASS	516	Q9UDR5
KTRPQNGSIILYNRK	CAMTA2	66	O94983
NKFLARYVSLPNQNK	ABHD4	41	Q8TB40
PNNKRVKNAVKYLQS	CCL17	76	Q92583
SGPRKKLFEYQQAQL	ARIH2	436	O95376
NLQRTKVRYNPSLKG	CA6	51	P23280
KPQAKQLQTRADYLI	CHD1	1296	O14646
QAPKIAQIKRNLSYG	DLGAP4	751	Q9Y2H0
YPSVRQKALNALNNI	ARMCX4	2096	Q5H9R4
YANRAKNIINKPTIN	KIF16B	351	Q96L93
NNQRIKASIPSIKYC	PGK2	36	P07205
NPQKKNYIFLRNAAE	RAE1	346	P78406
RPLRNLVSYLKQKQA	RBM15	886	Q96T37
QNKPGFLRKNQYTNT	RBM27	586	Q9P2N5
NQLVEQYKQKLLGPS	RBM28	731	Q9NW13
ITVKVNAPYNKINQR	CD274	126	Q9NZQ7
NQTQVNRYKISLLKP	RAD1	216	O60671
LLESKINPNTAYQKQ	PPP4R3A	51	Q6IN85
FGKALNPKRYQQTLE	ABCC3	711	O15438
SQRGQPLTKIQTLKY	MSGN1	156	A6NI15
LQLPYSKRKFSGQQR	DEPDC5	1511	O75140
VNFYVINGKRKRSQP	NFATC2	656	Q13469
NPLIYSLRNKEVKNA	OR8H2	286	Q8N162
LYDKINTKSSPQIRN	CASK	386	O14936
NPLIYSLQNKEIKAA	OR11H2	301	Q8NH07
NPLIYSLRNKDVKNA	OR8D2	286	Q9GZM6
NSRGKIIKPLQYQST	GNL2	51	Q13823
PAYQRAKKANQLASQ	NRAP	176	Q86VF7
NVPRQIQAKYLKGRT	IBTK	271	Q9P2D0
SNLNKYSTINKIPQL	KCNH7	321	Q9NS40
TAGYNSPVKLLNRNN	HEBP2	176	Q9Y5Z4
GRKYIPAKFQNANLS	DDX60L	1476	Q5H9U9
KKAPIQTYVLGANNQ	CWF19L1	61	Q69YN2
QSPSKQRSLYLLNKK	IBA57-DT	91	B1ANH7
GINLPKLKNLYLAQN	LRRC23	196	Q53EV4
VNPIIYSFRNKEIKN	OR5A2	286	Q8NGI9
QVQVNRQAVALPYKK	MUC2	4561	Q02817
RRYNPNEKLKVNFGT	MYLK2	431	Q9H1R3
LKLYDNPLTNESKQQ	NAA16	566	Q6N069
LFYVKKNNSQPQSLL	CSNKA2IP	596	A0A1B0GTH6
RTPLKKNQNASLYKD	FAM209B	96	Q5JX69
LLSNRYNAPFKKNIQ	DNAH8	1461	Q96JB1
VKTLKQYLLTQAQPG	ERAL1	316	O75616
NANKILNRPKRYNSG	F9	36	P00740
NKYAANRKSTGQLNL	FRYL	1906	O94915
LQPSIKFVRQQKYTQ	INTS2	836	Q9H0H0
ENAQKIQRGQIPSKY	DLG5	1641	Q8TDM6
SEKAINRNYLKQPVV	LCA5L	76	O95447
IITNQIPKYSNGNIK	NR3C1	756	P04150
QNAPEKKITLNGIYQ	FOXC2	86	Q99958
RENGNVAKTPRNTYK	MKI67	836	P46013
LLESKINPNTAYQKQ	PPP4R3B	51	Q5MIZ7
ATALKRKGPYTQQQN	NUDT13	306	Q86X67
FIPGQSLKRRQKTYN	PEG3	666	Q9GZU2
SPKRQLQFYRNLGKS	KCNAB2	31	Q13303
NPIIYSFRNKDVKNA	OR5AS1	286	Q8N127
SNLEVNKPKNRYANV	PTPRS	1411	Q13332
NYIDQRPAAKKSAQL	PACC1	266	Q9H813
NKLQTLRQQPFAYGT	PANK4	486	Q9NVE7
LIINSYGPIIKNNSK	PRTG	1036	Q2VWP7
NPLIYSLRNKNVKDA	OR8J2	286	Q8NGG1
FVASLLPFGNKRQNK	ARHGAP6	311	O43182
YLAFKRQQDLKSPNQ	CTNNA3	186	Q9UI47
EPVLLKQTYKQQGNT	DNAH1	3291	Q9P2D7
QDSPQQLLQAFLKYK	DYNC2H1	411	Q8NCM8
NITNNRGKKRYPDSK	DYRK4	346	Q9NR20
VTRLLQNYKKQPRNS	GSAP	781	A4D1B5
KPNFISRYRIQVGKN	FAXDC2	106	Q96IV6
NNYRPRINKLNSIKD	ABCE1	571	P61221
QLAATKKTQYQQLPV	BRCA2	3026	P51587
LQKYLNFDPRTAQKI	CAPN7	501	Q9Y6W3
VKRPYTNAQIQIKQG	CDC7	256	O00311
LQPKNKRSYAQNVTV	INTS14	391	Q96SY0
GLYEQLKQRQLTPKA	CFAP107	141	Q8N1D5
NLNRYNKQLSKVFPE	HEATR4	376	Q86WZ0
IKNAISLPQLNQAAY	CDC42EP1	116	Q00587
YPKDSVSLRKNQSVN	C1RL	286	Q9NZP8
NLIQKAGYLNLRNKT	APPL2	276	Q8NEU8
APVKFNKLLYNGRQN	COL8A1	631	P27658
LSYNKLKNIPTVNEN	LUM	261	P51884
NSRNSKQNRVIYKPI	ESCO2	161	Q56NI9
KRRKVQPPQQNYSLA	MBIP	301	Q9NS73
RANYVPALKLNQTLK	AHCTF1	961	Q8WYP5
SEKSQYNLSQPLLKR	DNAH9	671	Q9NYC9
QLYPNNKAAKTQLAV	FKBP4	381	Q02790
NSKGQRSNYALKILQ	GRIK4	366	Q16099
KAQTILAQYLDPQAK	GRK1	106	Q15835
LNYLQSSGKQIAKVP	SACS	591	Q9NZJ4
LYESFQNPKRRKNQS	PEX1	1256	O43933
PVGSLSQRKRQQYAK	CACNA1D	76	Q01668
NLEVNKPKNRYANVI	PTPRF	1371	P10586
NPLIYSLQNKEIKAA	OR11H1	301	Q8NG94
NPLIYSLQNKEIKAA	OR11H12	301	B2RN74
NLEVNKPKNRYANVI	PTPRD	1376	P23468
NTLPKKGLRYQLQSQ	NAV1	941	Q8NEY1
TERAYQKQPTIFQNK	RPS11	6	P62280
KQYLRNSNLTPQQKI	MEIOC	206	A2RUB1
QKYKQKLQTTQAPSL	SNX13	951	Q9Y5W8
NLLVERNKKQGYPAL	SENP2	421	Q9HC62
KLNKVQYSTRPGVND	TRIM45	356	Q9H8W5
YLANDVIQNSKRKGP	RPRD1B	61	Q9NQG5
DQLKQNATKARIPFY	SRP54	146	P61011
LNQSLSLKPYQKVGL	SMARCAD1	491	Q9H4L7
SILSRLKQQNYAPNL	SPATA21	381	Q7Z572
NPKTYNRAQDIQGIK	SLC26A9	516	Q7LBE3
SQPAYSQIQKLRGKN	RMI1	96	Q9H9A7
EYKRQALNSIQNAPK	SNX25	456	Q9H3E2
LQNASPKQRKQSVYT	PPP1R1C	61	Q8WVI7
KSQAPKNYQVLLGNI	PRSS47P	126	A8MTI9
QKYNKLRQPFFQKRS	SETSIP	81	P0DME0
KQSKLQDPRQYRQAN	KIAA1217	1766	Q5T5P2
QKYNKLRQPFFQKRS	SET	71	Q01105
QKTQPRSALKLYQDL	SLC3A1	541	Q07837
NLQPYIKRAAASKLQ	ARHGAP5	111	Q13017
NYQNGKNNVPRLKLS	SEMA3A	21	Q14563
NSNYLTRLQKPQDKL	PLB1	346	Q6P1J6
NKQTYSTEPNNLKAR	RPL28	21	P46779
QIQKARKSNVSYKNP	SUPT16H	501	Q9Y5B9
KQEFYQLLKNLINPS	RANBP6	16	O60518
PKYVSSKALQRQNSE	ERRFI1	356	Q9UJM3
NPLIYSLRNKDVNKA	OR5L2	286	Q8NGL0
DPSLANYLVQKAKQR	SUV39H1	111	O43463
RPKNLANITDSKNYL	SPATA1	386	Q5VX52
NYVKQKRSITRPNAG	SSH1	421	Q8WYL5
QNASRSFEKAKPNIY	CCDC54	226	Q8NEL0
NVSVPKKTRNNGTLY	CLPTM1L	91	Q96KA5
KPFYINGQNQIKVTR	CLCA2	181	Q9UQC9
QLVAIKTLKDYNNPQ	ROR1	501	Q01973
KNNIPANFTRSGNKL	FYTTD1	166	Q96QD9
IYKGNITPQLNKNTL	UHRF1BP1L	671	A0JNW5
NPSVYNKKRRATNIE	ZNF567	236	Q8N184
KAPYANTKRLQEENL	VIL1	601	P09327
NAVQKYLKNDVGRSP	TTLL8	451	A6PVC2
NLSRLNLTKYSQKPK	TTC8	176	Q8TAM2
LVVPVKTKYNFNNRG	XPNPEP1	541	Q9NQW7
QVKSLTQKVQAGAYP	NGDN	31	Q8NEJ9
RQQVKQYLSTTLGPK	TFE3	196	P19532
RYFGPNLLNTVKQKL	POLR2G	16	P62487
YLANDVIQNSKRKGP	RPRD1A	61	Q96P16
PKKSTVLQQQYNRVG	TLN1	426	Q9Y490
KLAQIRQQQYKFLPS	TLN1	2521	Q9Y490
YKLQTRPGFNKAQLA	SAP30L	126	Q9HAJ7
QKAEANYLRALQLKP	TMTC2	796	Q8N394
YTAKIQALNGPLRSN	TNC	1951	P24821
KPQAKRIIYFNDTAQ	ROS1	461	P08922
ELLKPKLVQNSTYQN	ZNF518A	1116	Q6AHZ1
SQTLRKKNKQYQIPD	ARHGAP18	156	Q8N392
TSQLASPLKLKYNQG	PLCH1	1381	Q4KWH8
KLAQIRQQQYKFLPT	TLN2	2521	Q9Y4G6
FNKILNSKNLLPAYR	ZNF687	501	Q8N1G0
LPSVYQKALGQREQK	TBCCD1	486	Q9NVR7
TLINPQGAKLNIYKR	VWA3B	906	Q502W6
ANKPIQYLENKTVLN	VWA3B	951	Q502W6
NSYEGQKQKVIQPRI	TMLHE	136	Q9NVH6
NIPAKILSYNRANRA	TOP1	611	P11387
IKNNILNLQAKGLSY	ZNF285	51	Q96NJ3
PNKGTFQIVYKSRNN	THUMPD1	191	Q9NXG2
PLQNQKILKRTGQRY	ZNF649	91	Q9BS31